Reckitt Benckiser Group (OTCMKTS:RBGLY) Earns Buy Rating from Analysts at Citigroup

Citigroup initiated coverage on shares of Reckitt Benckiser Group (OTCMKTS:RBGLYFree Report) in a research note issued to investors on Wednesday morning, MarketBeat Ratings reports. The brokerage issued a buy rating on the stock.

Several other research firms have also weighed in on RBGLY. Morgan Stanley lowered shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research note on Monday, December 15th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Reckitt Benckiser Group in a report on Monday, October 27th. Jefferies Financial Group restated a “hold” rating on shares of Reckitt Benckiser Group in a research note on Wednesday, January 7th. Barclays raised Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Monday, December 1st. Finally, Royal Bank Of Canada cut Reckitt Benckiser Group from an “outperform” rating to a “sector perform” rating in a research note on Wednesday. Two research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, Reckitt Benckiser Group currently has a consensus rating of “Moderate Buy”.

Get Our Latest Analysis on RBGLY

Reckitt Benckiser Group Price Performance

Shares of OTCMKTS RBGLY opened at $16.32 on Wednesday. The company has a quick ratio of 0.37, a current ratio of 0.56 and a debt-to-equity ratio of 1.01. Reckitt Benckiser Group has a 12 month low of $11.99 and a 12 month high of $16.80. The business has a fifty day simple moving average of $15.98 and a 200-day simple moving average of $15.34.

Reckitt Benckiser Group Company Profile

(Get Free Report)

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.

Read More

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.